ITMI20020514A1 - Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi - Google Patents

Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi

Info

Publication number
ITMI20020514A1
ITMI20020514A1 IT2002MI000514A ITMI20020514A ITMI20020514A1 IT MI20020514 A1 ITMI20020514 A1 IT MI20020514A1 IT 2002MI000514 A IT2002MI000514 A IT 2002MI000514A IT MI20020514 A ITMI20020514 A IT MI20020514A IT MI20020514 A1 ITMI20020514 A1 IT MI20020514A1
Authority
IT
Italy
Prior art keywords
release
tablet
constituted
active ingredient
controlled release
Prior art date
Application number
IT2002MI000514A
Other languages
English (en)
Italian (it)
Inventor
Lauretta Maggi
Ubaldo Conte
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Priority to IT2002MI000514A priority Critical patent/ITMI20020514A1/it
Publication of ITMI20020514A0 publication Critical patent/ITMI20020514A0/it
Priority to AU2003239789A priority patent/AU2003239789A1/en
Priority to CNB038094851A priority patent/CN100528146C/zh
Priority to EP03732266A priority patent/EP1482915B1/en
Priority to DE60330949T priority patent/DE60330949D1/de
Priority to PCT/EP2003/002536 priority patent/WO2003075897A1/en
Priority to US10/507,344 priority patent/US20050095295A1/en
Priority to JP2003574172A priority patent/JP4664595B2/ja
Priority to DK03732266.6T priority patent/DK1482915T3/da
Priority to AT03732266T priority patent/ATE454887T1/de
Priority to CA2478406A priority patent/CA2478406C/en
Priority to ES03732266T priority patent/ES2339438T3/es
Publication of ITMI20020514A1 publication Critical patent/ITMI20020514A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2002MI000514A 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi ITMI20020514A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ES03732266T ES2339438T3 (es) 2002-03-12 2003-03-12 Sistema terapeutico para la liberacion controlada de ingredientes activos.
DE60330949T DE60330949D1 (de) 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
CNB038094851A CN100528146C (zh) 2002-03-12 2003-03-12 控制活性成分释放的治疗系统
EP03732266A EP1482915B1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
AU2003239789A AU2003239789A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
PCT/EP2003/002536 WO2003075897A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
US10/507,344 US20050095295A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients
JP2003574172A JP4664595B2 (ja) 2002-03-12 2003-03-12 活性成分の放出を制御する治療システム
DK03732266.6T DK1482915T3 (da) 2002-03-12 2003-03-12 Terapeutisk system til kontrolleret frigørelse af aktive ingredienser
AT03732266T ATE454887T1 (de) 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
CA2478406A CA2478406C (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi

Publications (2)

Publication Number Publication Date
ITMI20020514A0 ITMI20020514A0 (it) 2002-03-12
ITMI20020514A1 true ITMI20020514A1 (it) 2003-09-12

Family

ID=11449490

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi

Country Status (12)

Country Link
US (1) US20050095295A1 (cg-RX-API-DMAC7.html)
EP (1) EP1482915B1 (cg-RX-API-DMAC7.html)
JP (1) JP4664595B2 (cg-RX-API-DMAC7.html)
CN (1) CN100528146C (cg-RX-API-DMAC7.html)
AT (1) ATE454887T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003239789A1 (cg-RX-API-DMAC7.html)
CA (1) CA2478406C (cg-RX-API-DMAC7.html)
DE (1) DE60330949D1 (cg-RX-API-DMAC7.html)
DK (1) DK1482915T3 (cg-RX-API-DMAC7.html)
ES (1) ES2339438T3 (cg-RX-API-DMAC7.html)
IT (1) ITMI20020514A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003075897A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
ATE551051T1 (de) * 2003-09-19 2012-04-15 Sun Pharma Advanced Res Co Ltd Orales arzneimittelabgabesystem
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
CA2607272A1 (en) * 2005-05-09 2006-11-16 Azur Pharma Limited Formulations of mast cell stabilizing agents for delivery to the colon
NZ563846A (en) * 2005-06-03 2010-03-26 Egalet As A drug delivery system for delivering active substances dispersed in a dispersion medium
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
CA2657437A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
ES2607209T3 (es) 2009-02-06 2017-03-29 Egalet Ltd. Composiciones farmacéuticas resistentes al abuso
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
US9622979B2 (en) * 2011-06-29 2017-04-18 Sun Pharmaceutical Industries Limited Multilayered dosage form
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
CN108697700B (zh) 2016-02-04 2021-08-17 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
AU2018231044B2 (en) 2017-03-08 2023-04-06 Cinrx Pharma, Llc Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
JP7034343B2 (ja) * 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
WO2020027927A1 (en) * 2018-07-30 2020-02-06 Insta Therapeutics, Inc. Sublingual diltiazem and methods of use
CN113274363B (zh) * 2021-04-29 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
CN2213539Y (zh) * 1994-04-29 1995-11-29 天津市激光技术研究所 包衣上带有小孔的缓释药片
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
US6004582A (en) * 1997-05-30 1999-12-21 Laboratorios Phoenix U.S.A, Inc. Multi-layered osmotic device
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
JP2003504415A (ja) * 1999-07-20 2003-02-04 メルク エンド カムパニー インコーポレーテッド 持続放出性薬物分散剤輸送装置
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento

Also Published As

Publication number Publication date
CA2478406C (en) 2011-02-08
AU2003239789A1 (en) 2003-09-22
JP2005526757A (ja) 2005-09-08
JP4664595B2 (ja) 2011-04-06
ES2339438T3 (es) 2010-05-20
CN1649571A (zh) 2005-08-03
ITMI20020514A0 (it) 2002-03-12
US20050095295A1 (en) 2005-05-05
DE60330949D1 (de) 2010-03-04
EP1482915B1 (en) 2010-01-13
DK1482915T3 (da) 2010-04-19
CA2478406A1 (en) 2003-09-18
CN100528146C (zh) 2009-08-19
WO2003075897A1 (en) 2003-09-18
ATE454887T1 (de) 2010-01-15
EP1482915A1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
DE60330949D1 (de) Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
Janczura et al. The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients
EP0977614B1 (de) Vorrichtung zum behandeln von malignen, tumorösen gewebebereichen
Field et al. Ultrasound‐Responsive Aqueous Two‐Phase Microcapsules for On‐Demand Drug Release
JP2005526757A5 (cg-RX-API-DMAC7.html)
DE69001831D1 (de) Wirkstoffabgabevorrichtung.
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
KR900011486A (ko) 하이드로겔에 의해 작동되는 분배장치
JP3784409B2 (ja) ディスペンサに送出ポートを形成するための方法及び装置
DE602004006497D1 (de) Wasserlösliches abgabeprodukt
DE69915346D1 (de) Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
BR9506028A (pt) Forma farmacêutica oral de múltipla dosagem unitária em tablete processos para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem e para o tratamento das doenças inflamatórias gastrointestinais em mamiíferos e no homem e embalagem de ampola de pressão transversal
DE60206078D1 (de) Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
CO6290635A2 (es) Composición farmaceútica que comprende una forma de dosis unitaria sólida de uno o más ingredientes activos y un polímero insoluble en agua y/o un polímero soluble en agua
DE60016920D1 (de) Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt
NO20034323L (no) Medisinske aerosolformuleringer
AR034517A1 (es) Formulacion farmaceutica
DE69904954D1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
US20130035632A1 (en) Decomposable Apparatus and Methods for Fabricating Same
DE58902457D1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
BRPI0812332A2 (pt) Embalagem para produtos de tabaco, e, método para fabricar a mesma
ES2256329T3 (es) Proceso par ala preparacion de un dispositivo de administracion oral.
ES2149341T3 (es) Expulsion de un material a partir de un dispositivo de liberacion.